Verona Pharma plc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Verona Pharma plc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2019 to Q4 2023.
  • Verona Pharma plc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $55.5M, a 14.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $55.5M +$7.05M +14.5% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $48.5M +$18.2M +60.2% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $30.3M -$69K -0.23% Dec 31, 2021 10-K 2023-03-07
Q4 2020 $30.3M +$16.8M +125% Dec 31, 2020 10-K 2022-03-03
Q4 2019 $13.5M Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.